FI55996C - FRAME STATION FOR 2,6-DIAMINO-DIHYDROPYRIDINE - Google Patents

FRAME STATION FOR 2,6-DIAMINO-DIHYDROPYRIDINE

Info

Publication number
FI55996C
FI55996C FI657/73A FI65773A FI55996C FI 55996 C FI55996 C FI 55996C FI 657/73 A FI657/73 A FI 657/73A FI 65773 A FI65773 A FI 65773A FI 55996 C FI55996 C FI 55996C
Authority
FI
Finland
Prior art keywords
dihydropyridine
diamino
frame station
station
frame
Prior art date
Application number
FI657/73A
Other languages
Finnish (fi)
Other versions
FI55996B (en
Inventor
Horst Meyer
Friedrich Bossert
Wulf Vater
Kurt Stoepel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI55996B publication Critical patent/FI55996B/en
Application granted granted Critical
Publication of FI55996C publication Critical patent/FI55996C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
FI657/73A 1972-03-06 1973-03-02 FRAME STATION FOR 2,6-DIAMINO-DIHYDROPYRIDINE FI55996C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2210687A DE2210687C3 (en) 1972-03-06 1972-03-06 2,6-diamino-3,5-diethoxycarbonyldihydropyridines, process for their preparation and pharmaceuticals containing them

Publications (2)

Publication Number Publication Date
FI55996B FI55996B (en) 1979-07-31
FI55996C true FI55996C (en) 1979-11-12

Family

ID=5838037

Family Applications (1)

Application Number Title Priority Date Filing Date
FI657/73A FI55996C (en) 1972-03-06 1973-03-02 FRAME STATION FOR 2,6-DIAMINO-DIHYDROPYRIDINE

Country Status (24)

Country Link
JP (2) JPS5626659B2 (en)
KR (1) KR780000119B1 (en)
AT (3) ATA925774A (en)
BE (1) BE796279A (en)
BG (2) BG22815A3 (en)
CA (1) CA988524A (en)
CH (2) CH577473A5 (en)
CS (2) CS182781B2 (en)
DD (1) DD106833A5 (en)
DE (1) DE2210687C3 (en)
DK (1) DK136061C (en)
ES (1) ES412323A1 (en)
FI (1) FI55996C (en)
FR (1) FR2181789B1 (en)
GB (1) GB1379005A (en)
HU (1) HU167089B (en)
IE (1) IE37370B1 (en)
IL (1) IL41664A (en)
LU (1) LU67147A1 (en)
NL (1) NL7303137A (en)
PL (2) PL92078B1 (en)
RO (2) RO63068A (en)
SE (1) SE384208B (en)
ZA (1) ZA731501B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (en) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-diamino-3,5-diethoxycarbonyldihydropyridines, process for their preparation and pharmaceuticals containing them
DE2406198C2 (en) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Process for the preparation of new 2-amino-6-dialkylamino-dihydropyridines
JPS5922594U (en) * 1982-08-03 1984-02-10 日本マランツ株式会社 earplug type headphone
JPS5922593U (en) * 1982-08-03 1984-02-10 日本マランツ株式会社 Horn mounting structure for headphone
JPS6282898A (en) * 1985-10-08 1987-04-16 Matsushita Electric Ind Co Ltd Headphone
JPS6293060U (en) * 1985-11-28 1987-06-13

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (en) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-diamino-3,5-diethoxycarbonyldihydropyridines, process for their preparation and pharmaceuticals containing them
US3855231A (en) * 1972-03-06 1974-12-17 Bayer Ag 2,6-diamino-1,4-dihydropyridine derivatives
DE2406198C2 (en) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Process for the preparation of new 2-amino-6-dialkylamino-dihydropyridines

Also Published As

Publication number Publication date
CH580589A5 (en) 1976-10-15
SE384208B (en) 1976-04-26
ZA731501B (en) 1973-11-28
CA988524A (en) 1976-05-04
KR780000119B1 (en) 1978-04-15
ES412323A1 (en) 1976-01-01
DE2210687A1 (en) 1973-09-20
FI55996B (en) 1979-07-31
DE2210687B2 (en) 1980-09-04
IE37370B1 (en) 1977-07-06
BG22815A3 (en) 1977-04-20
FR2181789B1 (en) 1976-12-03
JPS48103579A (en) 1973-12-25
CH577473A5 (en) 1976-07-15
RO61192A (en) 1976-09-15
IL41664A (en) 1976-01-30
NL7303137A (en) 1973-09-10
JPS5911584B2 (en) 1984-03-16
HU167089B (en) 1975-08-28
LU67147A1 (en) 1973-05-22
DK136061C (en) 1978-01-02
RO63068A (en) 1978-05-15
CS182781B2 (en) 1978-05-31
AT324338B (en) 1975-08-25
BE796279A (en) 1973-09-05
FR2181789A1 (en) 1973-12-07
AT327904B (en) 1976-02-25
BG20583A3 (en) 1975-12-05
GB1379005A (en) 1975-01-02
DD106833A5 (en) 1974-07-05
IL41664A0 (en) 1973-05-31
DE2210687C3 (en) 1981-09-24
JPS5626659B2 (en) 1981-06-19
ATA925774A (en) 1975-05-15
DK136061B (en) 1977-08-08
IE37370L (en) 1973-09-06
PL92078B1 (en) 1977-03-31
PL89256B1 (en) 1976-11-30
JPS5699460A (en) 1981-08-10
CS182792B2 (en) 1978-05-31

Similar Documents

Publication Publication Date Title
CH551170A (en) FRAME.
CH550106A (en) FRAME.
FI56153B (en) SOEMLOES, TUNNVAEGGIG BEHAOLLARE AV PLASTMATERIAL
MY7900243A (en) Substituted 16,17,18,19,20-pentanor-prostaglandins
TR20457A (en) 1,2,3-TIYADIYAZOL DERIVES
BE802531A (en) D-6-METHYL-ERGOLINES 2,8-DISUBSTITUTUEES
FI55996B (en) FRAME STATION FOR 2,6-DIAMINO-DIHYDROPYRIDINE
GB1406961A (en) 2,4,7-trioxopteridine derivatives
CH547425A (en) DOOR FRAME.
JPS5745162A (en) Substituted 1,2,4,5-tetrahydro-3h,3-benzoazepines
SE419980B (en) PROCEDURE FOR PREPARING SUBSTITUTED SUBSTITUTED 2-PHENYL-BICYCLO / 2,2,2 / OCT-3-YLALKYLAMINES
AT336252B (en) TOWER FRAME
HK15179A (en) 2,6-diaminoneburlarine derivatives
BE808336A (en) AZABENZO-1,5-DIAZEPINES
SE418084B (en) PROCEDURE FOR PREPARING 1,2,4-BENZOTIADIAZINE DERIVATIVE
CH554275A (en) REMOVABLE FRAME.
BE800350A (en) OXAPROSTAGLANDINS,
IL43666A0 (en) Substituted 9,10-dihydro-anthracenes
SU461929A1 (en) Method for preparing 5,6-dihydro-4n-1, 3,4-oxadiazines
BE799427A (en) BOUWCEL,
ES185403Y (en) PERFECTED FRAME.
AU5705273A (en) Frame members frame members
FI800580A (en) ANVAENDNING AV MONOACETALER AV AROMATISKA 1,2-DIKETONER SAOSOM FOTOSENSIBILISATORER
BE792384A (en) TELEVISION FRAME.
SE413190B (en) PROCEDURE FOR PREPARING SUBSTITUTED 1,2,4,5-TETRAHYDRO-3H, 3-BENZZEPINES